Magazine: Lula’s progress plan for Brazil: a year on
In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settlements in the US, the cell & gene therapy landscape in the US, the latest on ESG in pharma, and more.
In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settlements in the US, the cell & gene therapy landscape in the US, the latest on ESG in pharma, and more.
What's Your Reaction?
